Upcoming Events

American Society of Gene and Cell Therapy 22nd Annual Meeting

Apr 29 – May 2, 2019

Washington, D.C.

Identification of AAV Developed for Cystic Fibrosis (CF) Gene Therapy That Restores CFTR Function in Human CF Patient Cells
Presenter: Paul T. Wille, Ph.D., Case Western Reserve University, Cleveland, OH; Abeona Therapeutics Inc.
Date/Time: Tuesday April 30, 5:00 – 6:00 p.m. ET
Poster Board Number: 92
Session title: Cardiovascular and Pulmonary Diseases
Room: Columbia Hall
Abstract number: 528

Novel AAV Capsids Demonstrate Strong Retinal Expression in Non-Human Primates After Intravitreal Administration
Presenter: Brian Kevany, Ph.D., Abeona Therapeutics Inc.
Date/Time: Monday April 29, 5:00 – 6:00 p.m. ET
Session title: Neurologic Diseases
Room: Columbia Hall
Abstract number: 225

Intrathecal and Intravenous Combination Gene Therapy in the Mouse Model of Infantile Neuronal Ceroid Lipofuscinosis Extends Lifespan and Improves Behavioral Outcomes in Moderately Affected Mice
Presenter: Erik A. Lykken, Ph.D., University of Texas Southwestern Medical Center, Dallas, TX
Date/Time: Monday April 29, 11:45 a.m. – 12:00 p.m. ET
Session title: Tools, Delivery and Neuro Capsids
Room: Monroe

Annual Meeting of Stockholders

May 28, 2019 • 10:00am EDT

New York, New York

Past Events

WORLDSymposium™

Feb 4 – Feb 8, 2019

View All Past Events